Nevertheless, in line with the results in subcutaneous xenograft models, combined treatment of VC and anti-PD-L1 led to significant smaller tumor burdens than the single IgG Ctrl, VC or anti-PD-L1-treated group in orthotopic tumor models (Fig. 9f–h). Here, CD274 is linked to neoplasm.